NGNE
NGNE
US64135M1053
Neurogene Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 925.000
--
Cost of Revenue -- --
--
Gross Profit -- --
--
103.328.000 83.530.000
23.7%
Operating Income -103.328.000 -82.605.000
25.1%
Pretax Income -90.351.000 -75.144.000
20.2%
Net Income Common Stockholders -90.351.000 -75.144.000
20.2%
-- --
--
-- --
--
ende